Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912186110> ?p ?o ?g. }
- W2912186110 endingPage "317" @default.
- W2912186110 startingPage "304" @default.
- W2912186110 abstract "Cdc2-like kinase 1 (CLK1) and dual specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) are involved in the regulation of alternative pre-mRNA splicing. Dysregulation of this process has been linked to cancer progression and neurodegenerative diseases, making CLK1 and DYRK1A important therapeutic targets. Here we describe the synthesis of new pyrido[3,4-g]quinazoline derivatives and the evaluation of the inhibitory potencies of these compounds toward CDK5, CK1, GSK3, CLK1 and DYRK1A. Introduction of aminoalkylamino groups at the 2-position resulted in several compounds with low nanomolar affinity and selective inhibition of CLK1 and/or DYRK1A. Their evaluation on several immortalized or cancerous cell lines showed varying degree of cell viability reduction. Co-crystal structures of CLK1 with two of the most potent compounds revealed two alternative binding modes of the pyrido[3,4-g]quinazoline scaffold that can be exploited for future inhibitor design." @default.
- W2912186110 created "2019-02-21" @default.
- W2912186110 creator A5017132592 @default.
- W2912186110 creator A5021632256 @default.
- W2912186110 creator A5021719017 @default.
- W2912186110 creator A5021878955 @default.
- W2912186110 creator A5027358671 @default.
- W2912186110 creator A5038494102 @default.
- W2912186110 creator A5045820806 @default.
- W2912186110 creator A5052794004 @default.
- W2912186110 creator A5061635381 @default.
- W2912186110 creator A5069379688 @default.
- W2912186110 creator A5076882647 @default.
- W2912186110 creator A5079400181 @default.
- W2912186110 creator A5086343829 @default.
- W2912186110 creator A5088477266 @default.
- W2912186110 creator A5090315015 @default.
- W2912186110 date "2019-03-01" @default.
- W2912186110 modified "2023-10-08" @default.
- W2912186110 title "New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis" @default.
- W2912186110 cites W1974672059 @default.
- W2912186110 cites W1984811585 @default.
- W2912186110 cites W2023370651 @default.
- W2912186110 cites W2032956537 @default.
- W2912186110 cites W2033792938 @default.
- W2912186110 cites W2072728069 @default.
- W2912186110 cites W2083782307 @default.
- W2912186110 cites W2108300953 @default.
- W2912186110 cites W2108921801 @default.
- W2912186110 cites W2115346062 @default.
- W2912186110 cites W2124026197 @default.
- W2912186110 cites W2124301111 @default.
- W2912186110 cites W2153708797 @default.
- W2912186110 cites W2154714625 @default.
- W2912186110 cites W2159211495 @default.
- W2912186110 cites W2163341755 @default.
- W2912186110 cites W2180229411 @default.
- W2912186110 cites W2189824412 @default.
- W2912186110 cites W2332457800 @default.
- W2912186110 cites W2333316766 @default.
- W2912186110 cites W2340910305 @default.
- W2912186110 cites W2484968698 @default.
- W2912186110 cites W2569831701 @default.
- W2912186110 cites W2740631829 @default.
- W2912186110 cites W2830873838 @default.
- W2912186110 cites W4210675630 @default.
- W2912186110 cites W973171548 @default.
- W2912186110 doi "https://doi.org/10.1016/j.ejmech.2019.01.052" @default.
- W2912186110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30731399" @default.
- W2912186110 hasPublicationYear "2019" @default.
- W2912186110 type Work @default.
- W2912186110 sameAs 2912186110 @default.
- W2912186110 citedByCount "27" @default.
- W2912186110 countsByYear W29121861102019 @default.
- W2912186110 countsByYear W29121861102020 @default.
- W2912186110 countsByYear W29121861102021 @default.
- W2912186110 countsByYear W29121861102022 @default.
- W2912186110 countsByYear W29121861102023 @default.
- W2912186110 crossrefType "journal-article" @default.
- W2912186110 hasAuthorship W2912186110A5017132592 @default.
- W2912186110 hasAuthorship W2912186110A5021632256 @default.
- W2912186110 hasAuthorship W2912186110A5021719017 @default.
- W2912186110 hasAuthorship W2912186110A5021878955 @default.
- W2912186110 hasAuthorship W2912186110A5027358671 @default.
- W2912186110 hasAuthorship W2912186110A5038494102 @default.
- W2912186110 hasAuthorship W2912186110A5045820806 @default.
- W2912186110 hasAuthorship W2912186110A5052794004 @default.
- W2912186110 hasAuthorship W2912186110A5061635381 @default.
- W2912186110 hasAuthorship W2912186110A5069379688 @default.
- W2912186110 hasAuthorship W2912186110A5076882647 @default.
- W2912186110 hasAuthorship W2912186110A5079400181 @default.
- W2912186110 hasAuthorship W2912186110A5086343829 @default.
- W2912186110 hasAuthorship W2912186110A5088477266 @default.
- W2912186110 hasAuthorship W2912186110A5090315015 @default.
- W2912186110 hasBestOaLocation W29121861101 @default.
- W2912186110 hasConcept C11960822 @default.
- W2912186110 hasConcept C160110348 @default.
- W2912186110 hasConcept C184235292 @default.
- W2912186110 hasConcept C185592680 @default.
- W2912186110 hasConcept C2775880066 @default.
- W2912186110 hasConcept C2776414213 @default.
- W2912186110 hasConcept C2777736865 @default.
- W2912186110 hasConcept C2778866207 @default.
- W2912186110 hasConcept C55493867 @default.
- W2912186110 hasConcept C71240020 @default.
- W2912186110 hasConcept C97029542 @default.
- W2912186110 hasConceptScore W2912186110C11960822 @default.
- W2912186110 hasConceptScore W2912186110C160110348 @default.
- W2912186110 hasConceptScore W2912186110C184235292 @default.
- W2912186110 hasConceptScore W2912186110C185592680 @default.
- W2912186110 hasConceptScore W2912186110C2775880066 @default.
- W2912186110 hasConceptScore W2912186110C2776414213 @default.
- W2912186110 hasConceptScore W2912186110C2777736865 @default.
- W2912186110 hasConceptScore W2912186110C2778866207 @default.
- W2912186110 hasConceptScore W2912186110C55493867 @default.
- W2912186110 hasConceptScore W2912186110C71240020 @default.
- W2912186110 hasConceptScore W2912186110C97029542 @default.
- W2912186110 hasFunder F4320320879 @default.